Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 99.

Wolpert, Fabian; Weller, Michael; Berghoff, Anna Sophie; Rushing, Elisabeth; Füreder, Lisa Michaela; Petyt, Gregory; Leske, Henning; Andratschke, Nicolaus; Regli, Luca; Neidert, Marian Christoph; Stupp, Roger; Stahel, Rolf; Dummer, Reinhard; Frauenfelder, Thomas; Roth, Patrick; Reyns, Nicolas; Kaufmann, Philipp Antonio; Preusser, Matthias; Le Rhun, Emilie (2018). Diagnostic value of F-fluordesoxyglucose positron emission tomography for patients with brain metastasis from unknown primary site. European Journal of Cancer, 96:64-72.

Filli, Linard; Sutter, Tabea; Easthope, Christopher S; Killeen, Tim; Meyer, Christian; Reuter, Katja; Lörincz, Lilla; Bolliger, Marc; Weller, Michael; Curt, Armin; Straumann, Dominik; Linnebank, Michael; Zörner, Björn (2018). Profiling walking dysfunction in multiple sclerosis: characterisation, classification and progression over time. Scientific Reports, 8(1):4984.

Wolpert, Fabian; Weller, Michael; Berghoff, Anna Sophie; Rushing, Elisabeth; Füreder, Lisa Michaela; Petyt, Gregory; Leske, Henning; Andratschke, Nicolaus; Regli, Luca; Neidert, Marian Christoph; Stupp, Roger; Stahel, Rolf; Dummer, Reinhard; Frauenfelder, Thomas; Roth, Patrick; Reyns, Nicolas; Kaufmann, Philipp Antonio; Preusser, Matthias; Le Rhun, Emilie (2018). Diagnostic value of 18 F-fluordesoxyglucose positron emission tomography for patients with brain metastasis from unknown primary site. European Journal of Cancer, 96:64-72.

Suchorska, Bogdana; Giese, Armin; Biczok, Annamaria; Unterrainer, Marcus; Weller, Michael; Drexler, Mark; Bartenstein, Peter; Schüller, Ulrich; Tonn, Jörg-Christian; Albert, Nathalie L (2018). Identification of time-to-peak on dynamic 18F-FET-PET as a prognostic marker specifically in IDH1/2 mutant diffuse astrocytoma. Neuro-Oncology, 20(2):279-288.

Kessler, Tobias; Sahm, Felix; Sadik, Ahmed; Stichel, Damian; Hertenstein, Anne; Reifenberger, Guido; Zacher, Angela; Sabel, Michael; Tabatabai, Ghazaleh; Steinbach, Joachim; Sure, Ulrich; Krex, Dietmar; Grosu, Anca-L; Bewerunge-Hudler, Melanie; Jones, David; Pfister, Stefan M; Weller, Michael; Opitz, Christiane; Bendszus, Martin; von Deimling, Andreas; Platten, Michael; Wick, Wolfgang (2018). Molecular differences in IDH wildtype glioblastoma according to MGMT promoter methylation. Neuro-Oncology, 20(3):367-379.

Beier, Dagmar; Proescholdt, Martin; Reinert, Christiane; Pietsch, Torsten; Jones, David T W; Pfister, Stefan M; Hattingen, Elke; Seidel, Clemens; Dirven, Linda; Luerding, Ralf; Reijneveld, Jaap; Warmuth-Metz, Monika; Bonsanto, Matteo; Bremer, Michael; Combs, Stephanie; Rieken, Stefan; Herrlinger, Ulrich; Kuntze, Holger; Mayer-Steinacker, Regine; Moskopp, Dag; Schneider, Thomas; Beringer, Andreas; Schlegel, Uwe; Stummer, Walter; Welker, Helmut; Weyerbrock, Astrid; Paulsen, Frank; Rutkowski, Stefan; Weller, Michael; Wick, Wolfgang; et al (2018). Multicenter pilot study of radio-chemotherapy as first-line treatment for adults with medulloblastoma (NOA-07). Neuro-Oncology, 20(3):400-410.

Weiss, Tobias; Weller, Michael; Guckenberger, Matthias; Sentman, Charles L; Roth, Patrick (2018). NKG2D-based CAR-T cells and radiotherapy exert synergistic efficacy in glioblastoma. Cancer Research, 78(4):1031-1043.

Weiss, Tobias; Schneider, Hannah; Silginer, Manuela; Steinle, Alexander; Pruschy, Martin N; Polic, Bojan; Weller, Michael; Roth, Patrick (2018). NKG2D-dependent anti-tumor effects of chemotherapy and radiotherapy against glioblastoma. Clinical Cancer Research, 24(4):882-895.

Papa, Eleanna; Weller, Michael; Weiss, Tobias; Ventura, Elisa; Burghardt, Isabel; Szabó, Emese (2017). Negative control of the HGF/c-MET pathway by TGF-β: a new look at the regulation of stemness in glioblastoma. Cell Death and Disease, 8(12):3210.

Le Rhun, Emilie; Bertrand, Nicolas; Dumont, Aurélie; Tresch, Emmanuelle; Le Deley, Marie-Cécile; Mailliez, Audrey; Preusser, Matthias; Weller, Michael; Revillion, Françoise; Bonneterre, Jacques (2017). Identification of single nucleotide polymorphisms of the PI3K-AKT-mTOR pathway as a risk factor of central nervous system metastasis in metastatic breast cancer. European Journal of Cancer, 87:189-198.

Signorell, Rea D; Papachristodoulou, Alexandros; Xiao, Jiawen; Arpagaus, Bianca; Casalini, Tommaso; Grandjean, Joanes; Thamm, Jana; Steiniger, Frank; Luciani, Paola; Brambilla, Davide; Werner, Beat; Martin, Ernst; Weller, Michael; Roth, Patrick; Leroux, Jean-Christophe (2017). Preparation of PEGylated liposomes incorporating lipophilic lomeguatrib derivatives for the sensitization of chemo-resistant gliomas. International journal of pharmaceutics, 536(1):388-396.

Wick, Wolfgang; Gorlia, Thierry; Bendszus, Martin; Taphoorn, Martin; Sahm, Felix; Harting, Inga; Brandes, Alba A; Taal, Walter; Domont, Julien; Idbaih, Ahmed; Campone, Mario; Clement, Paul M; Stupp, Roger; Fabbro, Michel; Le Rhun, Emilie; Dubois, Francois; Weller, Michael; von Deimling, Andreas; Golfinopoulos, Vassilis; Bromberg, Jacoline C; Platten, Michael; Klein, Martin; van den Bent, Martin J (2017). Lomustine and Bevacizumab in Progressive Glioblastoma. New England Journal of Medicine, 377(20):1954-1963.

Louis, David N; Aldape, Ken; Brat, Daniel J; Capper, David; Ellison, David W; Hawkins, Cynthia; Paulus, Werner; Perry, Arie; Reifenberger, Guido; Figarella-Branger, Dominique; Wesseling, Pieter; Batchelor, Tracy T; Gregory Cairncross, J; Pfister, Stefan M; Rutkowski, Stefan; Weller, Michael; Wick, Wolfgang; von Deimling, Andreas (2017). cIMPACT-NOW (the consortium to inform molecular and practical approaches to CNS tumor taxonomy): a new initiative in advancing nervous system tumor classification. Brain Pathology, 27(6):851-852.

Schneider, Hannah; Lohmann, Birthe; Wirsching, Hans-Georg; Hasenbach, Kathy; Rushing, Elisabeth J; Frei, Karl; Pruschy, Martin; Tabatabai, Ghazaleh; Weller, Michael (2017). Age-associated and therapy-induced alterations in the cellular microenvironment of experimental gliomas. OncoTarget, 8(50):87124-87135.

Renfrow, Jaclyn J; Weller, Michael; Strowd, Roy E (2017). Meeting Update-World Federation of Neuro-Oncology Societies (WFNOS) Meeting 2017. Neuro-Oncology, 19(11):1457-1459.

Beyer, Ulrike; Brand, Frank; Martens, Helge; Weder, Julia; Christians, Arne; Elyan, Natalie; Hentschel, Bettina; Westphal, Manfred; Schackert, Gabriele; Pietsch, Torsten; Hong, Bujung; Krauss, Joachim K; Samii, Amir; Raab, Peter; Das, Anibh; Dumitru, Claudia A; Sandalcioglu, I Erol; Hakenberg, Oliver W; Erbersdobler, Andreas; Lehmann, Ulrich; Reifenberger, Guido; Weller, Michael; Reijns, Martin A M; Preller, Matthias; Wiese, Bettina; Hartmann, Christian; Weber, Ruthild G (2017). Rare ADAR and RNASEH2B variants and a type I interferon signature in glioma and prostate carcinoma risk and tumorigenesis. Acta Neuropathologica, 134(6):905-922.

Fierstra, Jorn; van Niftrik, Christiaan; Piccirelli, Marco; Bozinov, Oliver; Pangalu, Athina; Krayenbühl, Niklaus; Valavanis, Antonios; Weller, Michael; Regli, Luca (2017). Diffuse gliomas exhibit whole brain impaired cerebrovascular reactivity. Magnetic Resonance Imaging, 45:78-83.

Silginer, Manuela; Nagy, Sara; Happold, Caroline; Schneider, Hannah; Weller, Michael; Roth, Patrick (2017). Autocrine activation of the IFN signaling pathway may promote immune escape in glioblastoma. Neuro-Oncology, 19(10):1338-1349.

Weller, Michael; Butowski, Nicholas; Tran, David D; Recht, Lawrence D; Lim, Michael; Hirte, Hal; Ashby, Lynn; Mechtler, Laszlo; Goldlust, Samuel A; Iwamoto, Fabio; Drappatz, Jan; O'Rourke, Donald M; Wong, Mark; Hamilton, Mark G; Finocchiaro, Gaetano; Perry, James; Wick, Wolfgang; Green, Jennifer; He, Yi; Turner, Christopher D; Yellin, Michael J; Keler, Tibor; Davis, Thomas A; Stupp, Roger; Sampson, John H; ACT IV trial investigators (2017). Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial. Lancet Oncology, 18(10):1373-1385.

Berghoff, Anna S; Wolpert, Fabian; Holland-Letz, Tim; Koller, Romina; Widhalm, Georg; Gatterbauer, Brigitte; Dieckmann, Karin; Birner, Peter; Bartsch, Rupert; Zielinski, Christoph C; Weller, Michael; Preusser, Matthias (2017). Combining standard clinical blood values for improving survival prediction in patients with newly diagnosed brain metastases-development and validation of the LabBM score. Neuro-Oncology, 19(9):1255-1262.

Venturini, Elisa; Leanza, Luigi; Azzolini, Michele; Kadow, Stephanie; Mattarei, Andrea; Weller, Michael; Tabatabai, Ghazaleh; Edwards, Michael J; Zoratti, Mario; Paradisi, Cristina; Szabò, Ildikò; Gulbins, Erich; Becker, Katrin Anne (2017). Targeting the Potassium Channel Kv1.3 Kills Glioblastoma Cells. Neurosignals, 25(1):26-38.

Felsberg, Joerg; Hentschel, Bettina; Kaulich, Kerstin; Gramatzki, Dorothee; Zacher, Angela; Malzkorn, Bastian; Kamp, Marcel Alexander; Sabel, Michael C; Simon, Matthias; Westphal, Manfred; Schackert, Gabriele; Tonn, Jörg-Christian; Pietsch, Torsten; von Deimling, Andreas; Loeffler, Markus; Reifenberger, Guido; Weller, Michael (2017). Prognostic role of Epidermal growth factor receptor variant III (EGFRvIII) positivity in EGFR-amplified primary and recurrent glioblastomas. Clinical Cancer Research, 23(22):6846-6855.

Blumenthal, Deborah T; Gorlia, Thierry; Gilbert, Mark R; Kim, Michelle M; Burt Nabors, L; Mason, Warren P; Hegi, Monika E; Zhang, Peixin; Golfinopoulos, Vassilis; Perry, James R; Hyun Nam, Do; Erridge, Sara C; Corn, Benjamin W; Mirimanoff, René O; Brown, Paul D; Baumert, Brigitta G; Mehta, Minesh P; van den Bent, Martin J; Reardon, David A; Weller, Michael; Stupp, Roger (2017). Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG. Neuro-Oncology, 19(8):1119-1126.

Weller, Michael; van den Bent, Martin; Tonn, Jörg C; Stupp, Roger; Preusser, Matthias; Cohen-Jonathan-Moyal, Elizabeth; Henriksson, Roger; Le Rhun, Emilie; Balana, Carmen; Chinot, Olivier; Bendszus, Martin; Reijneveld, Jaap C; Dhermain, Frederic; French, Pim; Marosi, Christine; Watts, Colin; Oberg, Ingela; Pilkington, Geoffrey; Baumert, Brigitta G; Taphoorn, Martin J B; Hegi, Monika; Westphal, Manfred; Reifenberger, Guido; Soffietti, Riccardo; Wick, Wolfgang; European Association for Neuro-Oncology (EANO) (2017). Evidence-based management of adult patients with diffuse glioma - Authors' reply. Lancet Oncology, 18(8):e430-e431.

Reifenberger, Guido; Wirsching, Hans-Georg; Knobbe-Thomsen, Christiane B; Weller, Michael (2017). Advances in the molecular genetics of gliomas - implications for classification and therapy. Nature Reviews. Clinical Oncology, 14(7):434-452.

Ventura, Elisa; Weller, Michael; Burghardt, Isabel (2017). Cutting edge: ERK1 mediates the autocrine positive feedback loop of TGF-β and furin in glioma-initiating cells. Journal of Immunology, 198(12):4569-4574.

Galldiks, Norbert; Albert, Nathalie L; Sommerauer, Michael; Grosu, Anca L; Ganswindt, Ute; Law, Ian; Preusser, Matthias; Le Rhun, Emilie; Vogelbaum, Michael A; Zadeh, Gelareh; Dhermain, Frédéric; Weller, Michael; Langen, Karl-Josef; Tonn, Jörg C (2017). PET Imaging in Patients with Meningioma - Report of the RANO/PET Group. Neuro-Oncology, 19(12):1576-1587.

Seystahl, Katharina; Papachristodoulou, Alexandros; Burghardt, Isabel; Schneider, Hannah; Hasenbach, Kathy; Janicot, Michel; Roth, Patrick; Weller, Michael (2017). Biological Role and Therapeutic Targeting of TGF-β3 in Glioblastoma. Molecular Cancer Therapeutics, 16(6):1177-1186.

Weller, Michael; van den Bent, Martin; Tonn, Jörg C; Stupp, Roger; Preusser, Matthias; Cohen-Jonathan-Moyal, Elizabeth; Henriksson, Roger; Le Rhun, Emilie; Balana, Carmen; Chinot, Olivier; Bendszus, Martin; Reijneveld, Jaap C; Dhermain, Frederick; French, Pim; Marosi, Christine; Watts, Colin; Oberg, Ingela; Pilkington, Geoffrey; Baumert, Brigitta G; Taphoorn, Martin J B; Hegi, Monika; Westphal, Manfred; Reifenberger, Guido; Soffietti, Riccardo; Wick, Wolfgang; European Association for Neuro-Oncology (EANO) (2017). European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas. Lancet Oncology, 18(6):e315-e329.

Pace, Andrea; Dirven, Linda; Koekkoek, Johan A F; Golla, Heidrun; Fleming, Jane; Rudà, Roberta; Marosi, Christine; Le Rhun, Emilie; Grant, Robin; Oliver, Kathy; Oberg, Ingela; Bulbeck, Helen J; Rooney, Alasdair G; Henriksson, Roger; Pasman, H Roeline W; Oberndorfer, Stefan; Weller, Michael; Taphoorn, Martin J B; European Association of Neuro-Oncology (2017). European Association for Neuro-Oncology (EANO) guidelines for palliative care in adults with glioma. Lancet Oncology, 18(6):e330-e340.

Weller, Michael; Roth, Patrick; Preusser, Matthias; Wick, Wolfgang; Reardon, David A; Platten, Michael; Sampson, John H (2017). Vaccine-based immunotherapeutic approaches to gliomas and beyond. Nature Reviews. Neurology, 13(6):363-374.

Cimino, Patrick J; Zager, Michael; McFerrin, Lisa; Wirsching, Hans-Georg; Bolouri, Hamid; Hentschel, Bettina; von Deimling, Andreas; Jones, David; Reifenberger, Guido; Weller, Michael; Holland, Eric C (2017). Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery. Acta Neuropathologica Communications, 5(1):39.

van den Bent, Martin J; Weller, Michael; Wen, Patrick Y; Kros, Johan M; Aldape, Ken; Chang, Susan (2017). A clinical perspective on the 2016 WHO brain tumor classification and routine molecular diagnostics. Neuro-Oncology, 19(5):614-624.

Le Rhun, Emilie; Rudà, Roberta; Devos, Patrick; Hoang-Xuan, Khê; Brandsma, Dieta; Pérez Segura, Pedro; Soffietti, Riccardo; Weller, Michael (2017). Diagnosis and treatment patterns for patients with leptomeningeal metastasis from solid tumors across Europe. Journal of Neuro-Oncology, 133(2):419-427.

Herrlinger, Ulrich; Schäfer, Niklas; Fimmers, Rolf; Griesinger, Frank; Rauch, Michael; Kirchen, Heinz; Roth, Patrick; Glas, Martin; Bamberg, Michael; Martus, Peter; Thiel, Eckhard; Korfel, Agnieszka; Weller, Michael (2017). Early whole brain radiotherapy in primary CNS lymphoma: negative impact on quality of life in the randomized G-PCNSL-SG1 trial. Journal of Cancer Research and Clinical Oncology, 143(9):1815-1821.

Silginer, Manuela; Weller, Michael; Stupp, Roger; Roth, Patrick (2017). Biological activity of tumor-treating fields in preclinical glioma models. Cell Death and Disease, 8(4):e2753.

Mangani, Davide; Weller, Michael; Roth, Patrick (2017). The network of immunosuppressive pathways in glioblastoma. Biochemical Pharmacology, 130:1-9.

Gramatzki, Dorothee; Kickingereder, Philipp; Hentschel, Bettina; Felsberg, Jörg; Herrlinger, Ulrich; Schackert, Gabriele; Tonn, Jörg-Christian; Westphal, Manfred; Sabel, Michael; Schlegel, Uwe; Wick, Wolfgang; Pietsch, Torsten; Reifenberger, Guido; Loeffler, Markus; Bendszus, Martin; Weller, Michael (2017). Limited role for extended maintenance temozolomide for newly diagnosed glioblastoma. Neurology, 88(15):1422-1430.

Hundsberger, Thomas; Weller, Michael (2017). Bevacizumab: Zankapfel der Glioblastomtherapie. Praxis, 106(8):415-420.

Roth, Patrick; Gramatzki, Dorothee; Weller, Michael (2017). Management of Elderly Patients with Glioblastoma. Current Neurology and Neuroscience Reports:17:35.

Feddermann-Demont, Nina; Junge, Astrid; Weber, Konrad P; Weller, Michael; Dvořák, Jiří; Tarnutzer, Alexander A (2017). Prevalence of potential sports-associated risk factors in Swiss amyotrophic lateral sclerosis patients. Brain and Behavior, 7(4):e00630.

Weller, Michael; Roth, Patrick; Sahm, Felix; Burghardt, Isabel; Schuknecht, Bernhard; Rushing, Elisabeth J; Regli, Luca; Lindemann, Justin P; von Deimling, Andreas (2017). Durable Control of Metastatic AKT1-Mutant WHO Grade 1 Meningothelial Meningioma by the AKT Inhibitor, AZD5363. Journal of the National Cancer Institute, 109(3):1-4.

van Niftrik, Christiaan Hendrik Bas; Piccirelli, Marco; Bozinov, Oliver; Pangalu, Athina; Fisher, Joseph A; Valavanis, Antonios; Luft, Andreas R; Weller, Michael; Regli, Luca; Fierstra, Jorn (2017). Iterative analysis of cerebrovascular reactivity dynamic response by temporal decomposition. Brain and Behavior, 7(9):e00705.

Soffietti, Riccardo; Abacioglu, Ufuk; Baumert, Brigitta; Combs, Stephanie E; Kinhult, Sara; Kros, Johan M; Marosi, Christine; Metellus, Philippe; Radbruch, Alexander; Villa Freixa, Salvador S; Brada, Michael; Carapella, Carmine M; Preusser, Matthias; Le Rhun, Emilie; Rudà, Roberta; Tonn, Joerg C; Weber, Damien C; Weller, Michael (2017). Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO). Neuro-Oncology, 19(2):162-174.

Filli, Linard; Zörner, Björn; Kapitza, Sandra; Reuter, Katja; Lörincz, Lilla; Weller, David; Sutter, Tabea; Killeen, Tim; Gruber, Philipp; Petersen, Jens A; Weller, Michael; Linnebank, Michael (2017). Monitoring long-term efficacy of fampridine in gait-impaired patients with multiple sclerosis. Neurology, 88(9):832-841.

Cloughesy, Timothy; Finocchiaro, Gaetano; Belda-Iniesta, Cristóbal; Recht, Lawrence; Brandes, Alba A; Pineda, Estela; Mikkelsen, Tom; Chinot, Olivier L; Balana, Carmen; Macdonald, David R; Westphal, Manfred; Hopkins, Kirsten; Weller, Michael; Bais, Carlos; Sandmann, Thomas; Bruey, Jean-Marie; Koeppen, Hartmut; Liu, Bo; Verret, Wendy; Phan, See-Chun; Shames, David S (2017). Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Onartuzumab Plus Bevacizumab Versus Placebo Plus Bevacizumab in Patients With Recurrent Glioblastoma: Efficacy, Safety, and Hepatocyte Growth Factor and O(6)-Methylguanine-DNA Methyltransferase Biomarker Analyses. Journal of Clinical Oncology, 35(3):343-351.

Louis, David N; Aldape, Ken; Brat, Daniel J; Capper, David; Ellison, David W; Hawkins, Cynthia; Paulus, Werner; Perry, Arie; Reifenberger, Guido; Figarella-Branger, Dominique; Wesseling, Pieter; Batchelor, Tracy T; Cairncross, J Gregory; Pfister, Stefan M; Rutkowski, Stefan; Weller, Michael; Wick, Wolfgang; von Deimling, Andreas (2017). Announcing cIMPACT-NOW: the Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy. Acta Neuropathologica, 133(1):1-3.

Weller, Michael; Brada, M; Wong, T T; Vogelbaum, M (2017). Astrocytic tumors: diffuse astrocytoma, anaplastic astrocytoma, glioblastoma, and gliomatosis cerebri. In: Batchelor, Tracy T; Nishikawa, Ryo; Tarbell, Nancy J; Weller, Michael. Oxford textbook of neuro-oncology. Oxford: Oxford University Press, 27-36.

Schwarz, U; Weller, Michael; Spinas, Giatgen A; Kupferschmidt, Hugo (2017). Bewusstseinstörungen. In: Battegay, Edouard. Differenzialdiagnose Innerer Krankheiten : vom Symptom zur Diagnose. Stuttgart: Georg Thieme Verlag, 628-649.

Brötz, Doris; Weller, Michael (2017). Diagnostik und Therapie bei Bandscheibenschäden. Neurologie und Physiotherapie. Stuttgart: Thieme.

Stupp, Roger; Taillibert, Sophie; Kanner, Andrew; Read, William; Steinberg, David M; Lhermitte, Benoit; Toms, Steven; Idbaih, Ahmed; Ahluwalia, Manmeet S; Fink, Karen; Di Meco, Francesco; Lieberman, Frank; Zhu, Jay-Jiguang; Stragliotto, Giuseppe; Tran, David D; Brem, Steven; Hottinger, Andreas F; Kirson, Eilon D; Lavy-Shahaf, Gitit; Weinberg, Uri; Kim, Chae-Yong; Paek, Sun-Ha; Nicholas, Garth; Burna, Jordi; Hirte, Hal; Weller, Michael; Palti, Yoram; Hegi, Monika E; Ram, Zvi (2017). Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma. JAMA : the Journal of the American Medical Association, 318(23):2306-2316.

Roth, Patrick; Weller, Michael (2017). Immuntherapie von Hirntumoren. Aktuelle Neurologie, 44(06):400-408.

Roth, Patrick; Valavanis, Antonios; Weller, Michael (2017). Long-term control and partial remission after initial pseudoprogression of glioblastoma by anti–PD-1 treatment with nivolumab. Neuro-Oncology, 19(3):454-456.

Batchelor, Tracey T; Nishikawa, Ryo; Tarbell, Nancy J; Weller, Michael (2017). Oxford Textbook of Neuro-Oncology. Oxford: Oxford University Press.

Berriochoa, Camille; Weller, Michael; Berry, Danielle; Reddy, Chandana A; Koyfman, Shlomo; Tendulkar, Rahul (2017). Program director and chief resident perspectives on the educational environment of US radiation oncology programs. Practical Radiation Oncology, 7(1):e65-e70.

Battegay, E; Sandor, P; Weller, Michael; Hoffmann, U; Tato, F; Kraenzlin, M E; Jakob, F (2017). Schmerzen der Extremitäten. In: Battegay, E. Differenzialdiagnose Innerer Krankheiten : vom Symptom zur Diagnose. Stuttgart: Georg Thieme Verlag, 1072-1147.

Schwarz, U; Weller, Michael (2017). Schwindel. In: Battegay, Edouard. Differenzialdiagnose Innerer Krankheiten : vom Symptom zur Diagnose. Stuttgart: Georg Thieme Verlag, 586-610.

Ventura, Elisa; Weller, Michael; Macnair, Will; Eschbach, Katja; Beisel, Christian; Cordazzo, Cinzia; Claassen, Manfred; Zardi, Luciano; Burghardt, Isabel (2017). TGF-β induces oncofetal fibronectin, which in turn modulates TGF-β superfamily signaling in endothelial cells. Journal of Cell Science:jcs.209619.

Weller, Michael (2017). Tumoren des Nervensystems. In: Petrasch, Stephan; Ehninger, Gerhard. Update Hämatologie/Onkologie 2017. München: Lukon Verlag, 219-230.

Schliesser, Maximilian Georg; et al; Roth, Patrick; Weller, Michael (2016). Prognostic relevance of miRNA-155 methylation in anaplastic glioma. OncoTarget, 7(50):82028-82045.

Gramatzki, Dorothee; Frei, Karl; Cathomas, Gieri; Moch, Holger; Weller, Michael; Mertz, Kirsten Diana (2016). Interleukin-33 in human gliomas: Expression and prognostic significance. Oncology Letters, 12(1):445-452.

Seystahl, Katharina; Gramatzki, Dorothee; Roth, Patrick; Weller, Michael (2016). Pharmacotherapies for the treatment of glioblastoma - current evidence and perspectives. Expert Opinion on Pharmacotherapy, 17(9):1259-70.

Korfel, Agnieszka; Chamberlain, Marc; Neuwelt, Ed; Thiel, Eckhard; Doolittle, Nancy; Schlegel, Uwe; Dreyling, Martin; Rubenstein, James; Fischer, Lars; Björkholm, Magnus; Martus, Peter; Weller, Michael; Glantz, Michael (2016). Therapy for secondary CNS involvement in malignant lymphomas: No standard yet! Journal of Clinical Oncology, 34(15):1829-1830.

Wick, Wolfgang; Gorlia, Thierry; Bady, Pierre; Platten, Michael; van den Bent, Martin J; Taphoorn, Martin J B; Steuve, Jonathan; Brandes, Alba A; Hamou, Marie-France; Wick, Antje; Kosch, Markus; Weller, Michael; Stupp, Roger; Roth, Patrick; Golfinopoulos, Vassilis; Frenel, Jean-Sebastien; Campone, Mario; Ricard, Damien; Marosi, Christine; Villà, Salvador; Weyerbrock, Astrid; Hopkins, Kirsten; Homicsko, Krisztian; Lhermitte, Benoit; Pesce, Gianfranco Angelo; Hegi, Monika E (2016). Phase II study of radiotherapy and temsirolimus versus radiochemotherapy with temozolomide in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation (EORTC 26082). Clinical Cancer Research, 22(19):4797-4806.

Albert, Nathalie L; Weller, Michael; Suchorska, Bogdana; Galldiks, Norbert; Soffietti, Riccardo; Kim, Michelle M; la Fougère, Christian; Pope, Whitney; Lawrance, Ian C; Arbizu, Javier; Chamberlain, Marc C; Vogelbaum, Michael A; Ellingson, Ben M; Tonn, Joerg C (2016). Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas. Neuro-Oncology, 18(9):1199-1208.

Seystahl, Katharina; Stoecklein, Veit; Schüller, Ulrich; Rushing, Elisabeth; Nicolas, Guillaume; Schäfer, Niklaus; Ilhan, Harun; Pangalu, Athina; Weller, Michael; Tonn, Jörg-Christian; Sommerauer, Michael; Albert, Nathalie L (2016). Somatostatin-receptor-targeted radionuclide therapy for progressive meningioma: benefit linked to 68Ga-DOTATATE/-TOC uptake. Neuro-Oncology, 18(11):1538-1547.

Gramatzki, Dorothee; Dehler, Silvia; Rushing, Elisabeth Jane; Zaugg, Kathrin; Hofer, Silvia; Yonekawa, Yasuhiro; Bertalanffy, Helmut; Valavanis, Anton; Korol, Dimitri; Rohrmann, Sabine; Pless, Miklos; Oberle, Joachim; Roth, Patrick; Ohgaki, Hiroko; Weller, Michael (2016). Glioblastoma in the canton of Zurich, Switzerland revisited: 2005 to 2009. Cancer, 122(14):2206-2215.

Fierstra, Jorn; van Niftrik, Bas; Piccirelli, Marco; Burkhardt, Jan-Karl; Pangalu, Athina; Kocian, Roman; Valavanis, Antonios; Weller, Michael; Regli, Luca; Bozinov, Oliver (2016). Altered intraoperative cerebrovascular reactivity in brain areas of high-grade glioma recurrence. Magnetic Resonance Imaging, 34(6):803-808.

Berger, Michael S; Weller, Michael (2016). Preface. In: Berger, Michael S; Weller, Michael. Gliomas. Amsterdam: Elsevier, ix.

Seystahl, Katharina; Wick, Wolfgang; Weller, Michael (2016). Therapeutic options in recurrent glioblastoma-An update. Critical Reviews in Oncology/Hematology, 99:389-408.

Weller, Michael; Nabors, Louis Burt; Gorlia, Thierry; Leske, Henning; Rushing, Elisabeth; Bady, Pierre; Hicking, Christine; Perry, James; Hong, Yong-Kil; Roth, Patrick; Wick, Wolfgang; Goodman, Simon L; Hegi, Monika E; Picard, Martin; Moch, Holger; Straub, Josef; Stupp, Roger (2016). Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcome. OncoTarget, 7(12):15018-15032.

Herrlinger, Ulrich; Jones, David T W; Glas, Martin; Hattingen, Elke; Gramatzki, Dorothee; Stuplich, Moritz; Felsberg, Jörg; Bähr, Oliver; Gielen, Gerrit H; Simon, Matthias; Wiewrodt, Dorothee; Schabet, Martin; Hovestadt, Volker; Capper, David; Steinbach, Joachim P; von Deimling, Andreas; Lichter, Peter; Pfister, Stefan M; Weller, Michael; Reifenberger, Guido (2016). Erratum to: Gliomatosis cerebri: no evidence for a separate brain tumor entity. Acta Neuropathologica, 131(2):321-322.

Herrlinger, Ulrich; Jones, David T W; Glas, Martin; Hattingen, Elke; Gramatzki, Dorothee; Stuplich, Moritz; Felsberg, Jörg; Bähr, Oliver; Gielen, Gerrit H; Simon, Matthias; Wiewrodt, Dorothee; Schabet, Martin; Hovestadt, Volker; Capper, David; Steinbach, Joachim P; von Deimling, Andreas; Lichter, Peter; Pfister, Stefan M; Weller, Michael; Reifenberger, Guido (2016). Gliomatosis cerebri: no evidence for a separate brain tumor entity. Acta Neuropathologica, 131(2):309-319.

Linnebank, Michael; McDougall, Cameron G; Krueger, Stefanie; Biskup, Saskia; Neumann, Manuela; Weller, Michael; Valavanis, Antonios; Prudlo, Johannes (2016). Novel cases of amyotrophic lateral sclerosis after treatment of cerebral arteriovenous malformationss. Swiss Medical Weekly, 146:w14361.

Wirsching, Hans-Georg; Morel, Corinne; Gmür, Corinne; Neidert, Marian Christoph; Baumann, Christian Richard; Valavanis, Antonios; Rushing, Elisabeth Jane; Krayenbühl, Niklaus; Weller, Michael (2016). Predicting outcome of epilepsy after meningioma resection. Neuro-Oncology, 18(7):1002-1010.

Wegener, Susanne; Linnebank, Michael; Martin, Roland; Valavanis, Anton; Weller, Michael (2015). Clinically isolated neurosarcoidosis: A recommended diagnostic path. European Neurology, 73(1-2):71-77.

Reuss, David E; Kratz, Annekathrin; Sahm, Felix; Capper, David; Schrimpf, Daniel; Koelsche, Christian; Hovestadt, Volker; Bewerunge-Hudler, Melanie; Jones, David T W; Schittenhelm, Jens; Mittelbronn, Michel; Rushing, Elisabeth; Simon, Matthias; Westphal, Manfred; Unterberg, Andreas; Platten, Michael; Paulus, Werner; Reifenberger, Guido; Tonn, Joerg-Christian; Aldape, Kenneth; Pfister, Stefan M; Korshunov, Andrey; Weller, Michael; Herold-Mende, Christel; Wick, Wolfgang; Brandner, Sebastian; von Deimling, Andreas (2015). Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities. Acta Neuropathologica, 130(3):407-417.

Weller, Michael; Weber, Ruthild G; Willscher, Edith; Riehmer, Vera; Hentschel, Bettina; Kreuz, Markus; Felsberg, Jörg; Beyer, Ulrike; Löffler-Wirth, Henry; Kaulich, Kerstin; Steinbach, Joachim P; Hartmann, Christian; Gramatzki, D; Schramm, J; Westphal, M; Schackert, G; Simon, M; Martens, T; Boström, J; Hagel, C; Sabel, M; Krex, D; Tonn, J C; Wick, W; Noell, S; Schlegel, U; Radlwimmer, B; Pietsch, T; Loeffler, M; von Deimling, A; Binder, H; Reifenberger, G (2015). Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups. Acta Neuropathologica, 129(5):679-693.

Weller, Michael; Tabatabai, G; Kästner, B; Felsberg, J; Steinbach, J P; Wick, A; Schnell, O; Hau, P; Herrlinger, U; Sabel, M C; Wirsching, H G; Ketter, R; Bähr, O; Platten, M; Tonn, J C; Schlegel, U; Marosi, C; Goldbrunner, R; Stupp, R; Homicsko, K; Pichler, J; Nikkhah, G; Meixensberger, J; Vajkoczy, P; Kollias, S; Hüsing, J; Reifenberger, G; Wick, W (2015). MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial. Clinical Cancer Research, 21(9):2057-2064.

Weller, Michael; Wick, Wolfgang; Aldape, Ken; Brada, Michael; Berger, Mitchell; Pfister, Stefan M; Nishikawa, Ryo; Rosenthal, Mark; Wen, Patrick Y; Stupp, Roger; Reifenberger, Guido (2015). Glioma. Nature Reviews. Disease Primers, (2015):15017.

Weller, Michael (2015). Bevacizumab plus CCNU bei Rezidiv-Glioblastom. Der neue Standard? InFo Onkologie, 18(3):18.

Kumar, Karthiga Santhana; Pillong, Max; Kunze, Jens; Burghardt, Isabel; Weller, Michael; Grotzer, Michael A; Schneider, Gisbert; Baumgartner, Martin (2015). Computer-assisted quantification of motile and invasive capabilities of cancer cells. Scientific Reports, 5:15338.

Weller, Michael (2015). Neuer Standard ohne randomisierte Studie? INFO Neurologie & Psychiatrie, 17(2):33.

Weller, Michael (2015). Procholinerge Interventionen könnten sinnvoll sein. INFO Neurologie & Psychiatrie, 17(6):28.

Ineichen, Benjamin V; Keskitalo, Salla; Farkas, Melinda; Bain, Nadja; Kallweit, Ulf; Weller, Michael; Klotz, Luisa; Linnebank, Michael (2014). Genetic variants of homocysteine metabolism and multiple sclerosis: a case-control study. Neuroscience Letters, 562:75-78.

Tonder, Michaela; Eisele, Günter; Weiss, Tobias; Hofer, Silvia; Seystahl, Katharina; Valavanis, Antonios; Stupp, Roger; Weller, Michael; Roth, Patrick (2014). Addition of lomustine for bevacizumab-refractory recurrent glioblastoma. Acta Oncologica, 53(10):1436-1440.

Valavanis, Anton; Schwarz, Urs; Baumann, Christian R; Weller, Michael; Linnebank, Michael (2014). Amyotrophic lateral sclerosis after embolization of cerebral arterioveneous malformations. Journal of Neurology, 261(4):732-737.

Tonder, Michaela; Rushing, Elisabeth Jane; Grotzer, Michael; Sürücü, Oguzkan; Valavanis, Antonios; Buck, Alfred; Weller, Michael; Roth, Patrick (2014). Clinical reasoning: a 30-year-old woman with recurrent seizures and a cerebral lesion progressing over 2 decades. Neurology, 82(7):e56-e60.

Branscheidt, Meret; Frontzek, Karl; Bozinov, Oliver; Valavanis, Anton; Rushing, Elisabeth J; Weller, Michael; Wegener, Susanne (2014). Etoposide/carboplatin chemotherapy for the treatment of metastatic myxomatous cerebral aneurysms. Journal of Neurology, 261(4):828-830.

Mohme, Malte; Neidert, Marian C; Regli, Luca; Weller, Michael; Martin, Roland (2014). Immunological challenges for peptide-based immunotherapy in glioblastoma. Cancer Treatment Reviews, 40:248-258.

Lemke, Dieter; Weiler, Markus; Blaes, Jonas; Wiestler, Benedikt; Jestaedt, Leonie; Klein, Ann-Catherine; Löw, Sarah; Eisele, Günter; Radlwimmer, Bernhard; Capper, David; Schmieder, Kirsten; Mittelbronn, Michel; Combs, Stephanie E; Bendszus, Martin; Weller, Michael; Platten, Michael; Wick, Wolfgang (2014). Primary Glioblastoma Cultures: Can Profiling of Stem Cell Markers Predict Radiotherapy Sensitivity? Journal of Neurochemistry, 131(2):251-264.

Weller, Michael (2014). Primary central nervous system lymphoma in the elderly. Oncology Research and Treatment, 37(7-8):376-377.

Keskitalo, Salla; Farkas, Melinda; Hanenberg, Michael; Szodorai, Anita; Kulic, Luka; Semmler, Alexander; Weller, Michael; Nitsch, Roger M; Linnebank, Michael (2014). Reciprocal modulation of Aβ42 aggregation by copper and homocysteine. Frontiers in Aging Neuroscience:6:237.

Wirsching, Hans-Georg; Krishnan, Shanmugarajan; Florea, Ana-Maria; Frei, Karl; Krayenbühl, Niklaus; Hasenbach, Kathy; Reifenberger, Guido; Weller, Michael; Tabatabai, Ghazaleh (2014). Thymosin beta 4 gene silencing decreases stemness and invasiveness in glioblastoma. Brain, 137(2):433-448.

Vom Berg, Johannes; Vrohlings, Melissa; Haller, Sergio; Haimovici, Aladin; Kulig, Paulina; Sledzinska, Anna; Weller, Michael; Becher, Burkhard (2013). Intratumoral IL-12 combined with CTLA-4 blockade elicits T cell-mediated glioma rejection. Journal of Experimental Medicine, 210(13):2803-2811.

Tabatabai, Ghazaleh; Stupp, Roger; Wick, Wolfgang; Weller, Michael (2013). Malignant astrocytoma in elderly patients: where do we stand? Current Opinion in Neurology, 26(6):693-700.

Weller, Michael (2012). Angiogenesis inhibition: quo vadis? Neuro-Oncology, 14(11):1315.

Weller, Michael (2012). Primary central nervous system tumors: pathogenesis and therapy. In: Norden, A D; Reardon, D A; Wen, P Y C. Primary Central Nervous System Tumors. Pathogenesis and Therapy. New York: Springer, 937.

Wegener, S; Bremer, J; Komminoth, P; Jung, H H; Weller, Michael (2010). Paraneoplastic necrotizing myopathy with a mild inflammatory component: a case report and review of the literature. Case Reports in Oncology, 3(1):88-92.

This list was generated on Fri Jun 22 05:46:04 2018 CEST.